Quantcast

Latest Epigenomics AG Stories

2013-10-16 23:20:12

Reportbuyer.com just published a new market research report: In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Forecasts, 2012-2018. London (PRWEB) October 16, 2013 In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in...

2013-09-29 23:01:19

The report “Biomarkers Market – ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) – Global Trends & Forecasts (2013 – 2018)” says global biomarkers market shows a high growth potential and accounts for $17.5 billion in 2013. Dallas, Texas (PRWEB) September 29, 2013 A biomarker is an identifiable and measurable characteristic, which...

2013-06-13 23:27:32

RiboMed Biotechnologies, Inc. (http://www.ribomed.com), a company that develops epigenetic-based tests that provide improved cancer diagnosis and allow drug therapy to be personalized for the benefit of cancer patients, today announced that it has partnered with researchers at the Austrian Institute of Technology (AIT, Vienna) to commercialize their clinically validated lung cancer DNA methylation biomarkers. Lung cancer is the number-one cause of cancer deaths in both men and women in the...

2013-01-10 05:01:24

Leading National Reference Laboratory Services Provider, ARUP Laboratories, Introduces Blood Test to Aid in the Early Detection of Lung Cancer. Innovative Blood Test will assist Clinicians in Identifying Deadly Disease Earlier Salt Lake City, UT (PRWEB) January 09, 2013 ARUP Laboratories announced today that it is entering into an agreement with Kansas-based Oncimmune® USA LLC to offer EarlyCDT®-Lung, the blood test that aids in the risk assessment and the early detection of lung...

2010-01-11 09:15:00

MADISON, N.J., Jan. 11 /PRNewswire-FirstCall/ -- A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated (NYSE: DGX), the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths. The new test is based on DNA methylation of the Septin9 gene, a proprietary biomarker associated with colorectal cancer...

2008-10-27 06:00:09

-- Successfully qualified 17 PRESEPT clinical sites; 12 sites initiated -- Enrollment nearly 500 hundred subjects in first three months -- Expanded clinical site network to include first site in Germany -- Launched PRESEPT Study website found at www.presept.net -- Added Prof. Dr. Thomas Rosch to the Clinical Study Steering Committee -- Appointed Dr. Timothy R. Church responsible for study results analysis -- Clinical Study Steering Committee recommends...

2008-10-16 03:00:08

BERLIN and SEATTLE, Oct. 16, 2008 (GLOBE NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard), a cancer molecular diagnostics company developing tests based on DNA methylation, today reported positive final results from its prognostic prostate cancer study. "After testing all patient samples for methylation in the PITX2 gene we have successfully conducted our final analysis," commented Dr. Gunter Weiss, Vice President Product Development at Epigenomics. "This analysis shows that...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.